Cover Image
市場調查報告書

中國的真菌性皮膚疾病治療藥市場

Anti Dermatomycosis Skin Drugs Markets in China

出版商 Asia Market Information & Development 商品編碼 81741
出版日期 內容資訊 英文 221 Pages
訂單完成後即時交付
價格
Back to Top
中國的真菌性皮膚疾病治療藥市場 Anti Dermatomycosis Skin Drugs Markets in China
出版日期: 2016年01月01日 內容資訊: 英文 221 Pages
簡介

本報告提供中國的真菌性皮膚疾病治療藥市場相關調查分析、中國的商務環境、真菌性皮膚疾病治療藥的產業結構、主要治療藥的銷售額、市場佔有率、市場預測、關於進入中國市場的分析、主要製造商的目錄等彙整資料。

第1章 簡介

  • 調查範圍、調查手法
  • 摘要整理

第2章 商務環境

  • 經濟預測
    • 主要的經濟指標
    • 工業生產量
    • 人口及人力資源
    • 外國投資
    • 國際貿易
  • 金融及稅金的法規
    • 銀行制度及法規
    • 外匯
    • 稅金、關稅等

第3章 真菌性皮膚疾病治療藥的產業評估

  • 產業結構
  • 市場規模
  • 推動市場成長要素
  • 銷售額
  • 主要製造商的設備據點、銷售量
  • 主要製造商的市場佔有率
  • 勞動成本
  • 潛在的參與企業
  • 主要經銷商
  • 主要的外國投資
  • 技術開發

第4章 真菌性皮膚疾病治療藥的生產和需求

  • 概要
  • 各地區需求
  • 銷售額
  • 銷售額、市場佔有率:Fluconazole
  • 銷售額、市場佔有率:Itraconazole
  • 銷售額、市場佔有率:Terbinafine
  • 銷售額、市場佔有率:Econazole
  • 銷售額、市場佔有率:Miconazole Nitrate
  • 銷售額、市場佔有率:Amphotericin B
  • 銷售額、市場佔有率:Ketoconazole
  • 銷售額、市場佔有率:Clotrimazole
  • 銷售額、市場佔有率:Caspofungin
  • 銷售額、市場佔有率:其他
  • 進出口
  • 價格趨勢

第5章 真菌性皮膚疾病治療藥的市場預測

  • 市場預測:概要
  • 政府法規
  • 醫療保險產業概要
  • 消費者支出趨勢
  • 人口統計趨勢
  • 醫療產業趨勢
  • 醫院、病床數
  • 醫生、上醫院

第5章 市場進入途徑

  • 進入中國市場:概要
    • 中國的流通系統
    • 真菌性皮膚疾病治療藥的通路
    • 運輸及運輸基礎設施
    • 通訊
  • 進入中國市場
    • 對中國出口
    • 間接出口
    • 直接出口
    • 專利及委託製造
    • 中國的集合
    • 委託製造
    • 貿易的認證
    • 投資
    • 資本聯盟
    • 共同聯盟
    • 完全外資企業

第7章 主要製造商的目錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 818

China's demand for Anti Dermatomycosis Skin Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2005, 2010 and 2015) and long-term forecasts through 2020 and 2025 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments' industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

TABLE OF CONTENTS

I. INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

II. BUSINESS ENVIRONMENT

  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
  • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

III. ANTI DERMATOMYCOSIS SKIN DRUGS INDUSTRY ASSESSMENTS

  • Anti Dermatomycosis Skin Drugs Industry Structure
  • Market Size
  • Market Growth Driver
  • Anti Dermatomycosis Skin Drugs Sales Volume
  • Major Producer Facility Locations and Sales Volume
  • Market Share of Key Producers
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investments
  • Technology Development

IV. ANTI DERMATOMYCOSIS SKIN DRUGS PRODUCTION AND DEMAND

  • Overview
  • Demand of Anti Dermatomycosis Skin Drugs by Region
  • Anti Dermatomycosis Skin Drugs Sales Volume
  • Fluconazole Sales Volume and Market Share
  • Itraconazole Sales Volume and Market Share
  • Terbinafine Sales Volume and Market Share
  • Econazole Sales Volume and Market Share
  • Miconazole Nitrate Sales Volume and Market Share
  • Amphotericin B Sales Volume and Market Share
  • Ketoconazole Sales Volume and Market Share
  • Clotrimazole Sales Volume and Market Share
  • Caspofungin Sales Volume and Market Share
  • Other Anti Dermato Mycosis Skin Drugs Sales Volume and Market Share
  • Anti Dermatomycosis Skin Drugs Imports and Exports
  • Pricing Trends

V. ANTI DERMATOMYCOSIS SKIN DRUGS MARKET OUTLOOK

  • Anti Dermatomycosis Skin Drugs Markets Outlook Overview Concrete Government Regulations
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Northeast
  • North
  • Southeast
  • Central
  • Southwest
  • Northwest
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds

VI. MARKET ENTRY CHANNELS

  • China Market Entry Overview
  • China's Distribution System
  • Anti Peptic Ulcer Drugs Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China's Market Entry
  • Export to China
  • Indirect Export
  • Direct Export
  • License and Contract Manufacture
  • Assembling in China
  • Contract Manufacturing
  • Trade Permit
  • Investment
  • Equity Joint Venture
  • Contractual Joint Venture
  • Wholly Foreign-Owned Enterprise

VII. ANTIFREEZE & THAWING AGENT PRODUCER DIRECTORY

  • Anti Dermatomycosis Skin Drugs Producer Profiles and Directory

LIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade

III. ANTI DERMATOMYCOSIS SKIN DRUGS INDUSTRY ASSESSMENTS

  • Anti Dermatomycosis Skin Drugs Sales Volume
  • Major Producer Facility Locations
  • Major Anti Dermatomycosis Skin Drugs Producer Sales Volume
  • Market Share of Key Producers
  • Major Foreign Investments

IV. ANTI DERMATOMYCOSIS SKIN DRUGS PRODUCTION AND DEMAND

V. ANTI DERMATOMYCOSIS SKIN DRUGS MARKET OUTLOOK

  • Total Anti Peptic Ulcer Drugs Consumption
  • Consumer Spending Trend
  • The Structure of Per Capita Expenditure in the Northeast of China
  • The Structure of Per Capita Expenditure in the North of China
  • The Structure of Per Capita Expenditure in the Southeast of China
  • The Structure of Per Capita Expenditure in the Central of China
  • The Structure of Per Capita Expenditure in the Southwest of China
  • The Structure of Per Capita Expenditure in the Northwest of China
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds

LIST OF CHARTS

I. INTRODUCTION

  • Anti Dermatomycosis Skin Drugs Sales Volume

II. BUSINESS ENVIRONMENT

  • China's GDP and Growth Rate
  • Industrial Output by Ownership
  • China's Imports and Exports

III. ANTIFREEZE & THAWING AGENT INDUSTRY ASSESSMENTS

  • Anti Dermatomycosis Skin Drugs Sales Volume

IV. ANTIFREEZE & THAWING AGENT PRODUCTION AND DEMAND

  • Anti Dermatomycosis Skin Drugs Sales Volume
  • Worldwide Anti Dermatomycosis Skin Drugs Demand by Region
  • Fluconazole Sales Volume and Market Share
  • Itraconazole Sales Volume and Market Share
  • Terbinafine Sales Volume and Market Share
  • Econazole Sales Volume and Market Share
  • Miconazole Sales Volume and Market Share
  • Amphotericin B Sales Volume and Market Share
  • Ketoconazole Sales Volume and Market Share
  • Clotrimazole Sales Volume and Market Share
  • Caspofungin Sales Volume and Market Share
  • Other Anti Dermatomycosis Skin Drugs Sales Volume and Market Share
  • Anti Dermatomycosis Skin Drugs Import, Export and Net Import
  • Fluconazole Import, Export and Net Import
  • Itraconazole Import, Export and Net Import
  • Terbinafine Import, Export and Net Import
  • Econazole Import, Export and Net Import
  • Miconazole Nitrate Import, Export and Net Import
  • Amphotericin B Import, Export and Net Import
  • Ketoconazole Import, Export and Net Import
  • Clotrimazole Import, Export and Net Import
  • Caspofungin Import, Export and Net Import
  • Other Import, Export and Net Import

V. ANTI DERMATOMYCOSIS SKIN DRUGS MARKET OUTLOOK

VI. MARKETING STRATEGIES

  • China's Distribution Channel
Back to Top